| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0018 | 0.9 |